We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The review of the safety of isotretinoin has concluded.
Foresight project looking at how future scientific advances may affect our understanding of addiction and drug use.
Apply for a High Potential Individual (HPI) visa if you've been awarded a qualification by an eligible university in the last 5 years - eligibility, fees, documents, switch, bring your partner and children
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
This Spend Control ceased as a requirement on 1st February 2023. Other Cabinet Office Spending Controls remain operational.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
You must tell DVLA if you have a traumatic brain injury - download the form
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
You must tell DVLA if you have hypoxic brain damage - download the correct form to let them know
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Check the tariff classification for vitamin gummies.
What Works to Prevent Violence against Women and Girls: funding opportunity. Aims to build knowledge on what works to prevent violence against women and girls (VAWG).
You must tell DVLA if you have a brain aneurysm
You must tell DVLA if you have a brain abscess, cyst or encephalitis - download the correct form to let them know
The government is today investing a total of £45 million in the UK's quantum sector - as part of its commitment to transforming into a quantum-enabled economy by 2033 – seizing this technology’s potential to overhaul healthcare, energy, transport and...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.